1. Home
  2. Analysis
  3. Acne-aggravated
  4. Application-site-irritation

Acne aggravated and Application site irritation

Summary:

Application site irritation is found among people with Acne aggravated, especially for people who are female, 30-39 old.

The study analyzes which people have Application site irritation with Acne aggravated. It is created by eHealthMe based on reports of 81 people who have Acne aggravated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Acne aggravated?

Acne aggravated (acne - a skin disease) is found to be associated with 1,229 drugs and 527 conditions by eHealthMe. Check the latest studies of Acne aggravated.

What is Application site irritation?

Application site irritation is found to be associated with 391 drugs and 697 conditions by eHealthMe. Check the latest studies of Application site irritation.

On Jul, 12, 2026

81 people who have Acne Aggravated and Application Site Irritation are studied.

Would you have Application site irritation when you have Acne aggravated?

Gender of people who have Acne Aggravated and experienced Application Site Irritation *:

  • female: 72.31 %
  • male: 27.69 %

Age of people who have Acne Aggravated and experienced Application Site Irritation *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 20 %
  • 20-29: 24 %
  • 30-39: 34 %
  • 40-49: 6 %
  • 50-59: 10 %
  • 60+: 6 %

Common co-existing conditions for these people *:

  1. Skin Hyperpigmentation (disorders affect the colour of your skin): 2 people, 2.47%
  2. Skin Wrinkling (wrinkle on skin): 1 person, 1.23%
  3. Skin Irritation: 1 person, 1.23%
  4. Scar: 1 person, 1.23%
  5. Rosacea (a skin condition that causes facial redness): 1 person, 1.23%
  6. Menstruation Irregular: 1 person, 1.23%
  7. Irritable Bowel Syndrome: 1 person, 1.23%
  8. Indigestion: 1 person, 1.23%
  9. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 1 person, 1.23%
  10. Dry Eyes (lack of adequate tears): 1 person, 1.23%

Common drugs taken by these people *:

  1. Aczone: 9 people, 11.11%
  2. Adapalene: 5 people, 6.17%
  3. Veltin: 4 people, 4.94%
  4. Fabior: 4 people, 4.94%
  5. Differin: 4 people, 4.94%
  6. Tretinoin: 3 people, 3.70%
  7. Epiduo: 3 people, 3.70%
  8. Duac: 2 people, 2.47%
  9. Epiduo Forte: 2 people, 2.47%
  10. Clindamycin Phosphate And Benzoyl Peroxide: 2 people, 2.47%

Common symptoms for these people *:

  1. Application Site Erythema (redness of the skin at application site): 36 people, 44.44%
  2. Application Site Dryness: 26 people, 32.10%
  3. Application Site Pain: 20 people, 24.69%
  4. Application Site Pruritus (application site severe itching of the skin): 14 people, 17.28%
  5. Drug Ineffective: 13 people, 16.05%
  6. Rashes (redness): 10 people, 12.35%
  7. Application Site Exfoliation (application site removal of the oldest dead skin cells on the skin's outermost surface): 9 people, 11.11%
  8. Application Site Swelling: 8 people, 9.88%
  9. Application Site Rash: 6 people, 7.41%
  10. Dry Skin: 6 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Application site irritation?

- Check whether Application site irritation is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Application site irritation:

All the conditions that are associated with Application site irritation:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Application site irritation and Acne aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.